Application

CTX001

Vertex Pharmaceuticals Incorporated

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97267617
Filing Date: 02/15/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97267617
MARK INFORMATION
*MARK CTX001
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT CTX001
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Vertex Pharmaceuticals Incorporated
*MAILING ADDRESS 50 Northern Avenue
*CITY Boston
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02210
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Massachusetts
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of thalassemia and sickle cell disease
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Providing medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Timothy H. Hiebert
ATTORNEY DOCKET NUMBER 110047.634.5
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Womble Bond Dickinson (US) LLP
STREET 470 Atlantic Ave.
CITY Boston
STATE Massachusetts
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 02210-2228
PHONE 857-287-3180
EMAIL ADDRESS timothy.hiebert@wbd-us.com
OTHER APPOINTED ATTORNEY Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz, Nicholas B. Hawkins, Jack B. Hicks, Sarah Anne Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle
CORRESPONDENCE INFORMATION
NAME Timothy H. Hiebert
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE timothy.hiebert@wbd-us.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) TMdocketing@wbd-us.com; Elizabeth.Sousa@wbd-us.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE /Timothy H. Hiebert/
SIGNATORY'S NAME Timothy H. Hiebert
SIGNATORY'S POSITION Attorney of record, Massachusetts bar member
SIGNATORY'S PHONE NUMBER 857-287-3180
DATE SIGNED 02/15/2022
SIGNATURE METHOD Signed directly within the form



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97267617
Filing Date: 02/15/2022

To the Commissioner for Trademarks:

MARK: CTX001 (Standard Characters, see mark)
The literal element of the mark consists of CTX001. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Vertex Pharmaceuticals Incorporated, a corporation of Massachusetts, having an address of
      50 Northern Avenue
      Boston, Massachusetts 02210
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of thalassemia and sickle cell disease
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Providing medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Timothy H. Hiebert. Other appointed attorneys are Peter B. Bromaghim, Carla H. Clements, Melissa G. Ferrario, Anne C. Fleeson, William S. Fultz, Nicholas B. Hawkins, Jack B. Hicks, Sarah Anne Keefe, Laura A. Kees, Kelli A. Ovies, Randel S. Springer, Michael A. Tobin, Emily Scheible Whittaker, Jeffrey S. Whittle. Timothy H. Hiebert of Womble Bond Dickinson (US) LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      470 Atlantic Ave.
      Boston, Massachusetts 02210-2228
      United States
      857-287-3180(phone)
      timothy.hiebert@wbd-us.com
The docket/reference number is 110047.634.5.
Timothy H. Hiebert submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Timothy H. Hiebert
       PRIMARY EMAIL FOR CORRESPONDENCE: timothy.hiebert@wbd-us.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): TMdocketing@wbd-us.com; Elizabeth.Sousa@wbd-us.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Timothy H. Hiebert/   Date: 02/15/2022
Signatory's Name: Timothy H. Hiebert
Signatory's Position: Attorney of record, Massachusetts bar member
Signatory's Phone Number: 857-287-3180
Signature method: Signed directly within the form
Payment Sale Number: 97267617
Payment Accounting Date: 02/15/2022

Serial Number: 97267617
Internet Transmission Date: Tue Feb 15 13:04:53 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.X.XX-202202151304531559
09-97267617-8105f58ae842ac5cb78ef5632762
a08756931efdb5751e83ace1939828a419f8e-DA
-04521033-20220215125504570404

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed